Ignacio Atal

867 total citations
20 papers, 516 citations indexed

About

Ignacio Atal is a scholar working on Statistics, Probability and Uncertainty, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ignacio Atal has authored 20 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Statistics, Probability and Uncertainty, 9 papers in Economics and Econometrics and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ignacio Atal's work include Meta-analysis and systematic reviews (11 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Ethics in Clinical Research (4 papers). Ignacio Atal is often cited by papers focused on Meta-analysis and systematic reviews (11 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Ethics in Clinical Research (4 papers). Ignacio Atal collaborates with scholars based in France, United States and United Kingdom. Ignacio Atal's co-authors include Philippe Ravaud, Isabelle Boutron, Agnès Dechartres, Raphaël Porcher, Ludovic Trinquart, Carolina Riveros, David Moher, Kay Dickersin, Douglas G. Altman and Élodie Perrodeau and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and BMJ.

In The Last Decade

Ignacio Atal

18 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ignacio Atal France 11 205 154 115 57 53 20 516
Cole Wayant United States 19 457 2.2× 231 1.5× 288 2.5× 120 2.1× 14 0.3× 67 903
Nadera Ahmadzai Canada 15 286 1.4× 32 0.2× 109 0.9× 55 1.0× 13 0.2× 30 788
Elke Hausner Germany 10 132 0.6× 96 0.6× 149 1.3× 93 1.6× 34 0.6× 18 437
Kevin M. Fain United States 8 86 0.4× 140 0.9× 151 1.3× 38 0.7× 10 0.2× 16 418
D. G. Altman United Kingdom 5 214 1.0× 174 1.1× 110 1.0× 69 1.2× 9 0.2× 6 743
Graham Wheeler United Kingdom 10 80 0.4× 164 1.1× 125 1.1× 65 1.1× 16 0.3× 31 847
Lang’o Odondi United Kingdom 9 69 0.3× 131 0.9× 54 0.5× 50 0.9× 15 0.3× 11 573
Pamela Tenaerts United States 8 40 0.2× 96 0.6× 144 1.3× 94 1.6× 14 0.3× 18 363
Natalie McGauran Germany 15 235 1.1× 319 2.1× 257 2.2× 114 2.0× 6 0.1× 24 937

Countries citing papers authored by Ignacio Atal

Since Specialization
Citations

This map shows the geographic impact of Ignacio Atal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignacio Atal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignacio Atal more than expected).

Fields of papers citing papers by Ignacio Atal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ignacio Atal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignacio Atal. The network helps show where Ignacio Atal may publish in the future.

Co-authorship network of co-authors of Ignacio Atal

This figure shows the co-authorship network connecting the top 25 collaborators of Ignacio Atal. A scholar is included among the top collaborators of Ignacio Atal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ignacio Atal. Ignacio Atal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Atal, Ignacio, P. Smith, Philippe Ravaud, et al.. (2020). Reporting quality of studies using machine learning models for medical diagnosis: a systematic review. BMJ Open. 10(3). e034568–e034568. 69 indexed citations
3.
Bertizzolo, Lorenzo, Patrick M. Bossuyt, Ignacio Atal, Philippe Ravaud, & Agnès Dechartres. (2020). External factors may influence Cochrane reviewers when classifying the risk of bias of original reports. Journal of Clinical Epidemiology. 123. 1–8. 1 indexed citations
4.
5.
Bertizzolo, Lorenzo, Patrick M. Bossuyt, Ignacio Atal, Philippe Ravaud, & Agnès Dechartres. (2019). Disagreements in risk of bias assessment for randomised controlled trials included in more than one Cochrane systematic reviews: a research on research study using cross-sectional design. BMJ Open. 9(4). e028382–e028382. 21 indexed citations
6.
Atal, Ignacio, Raphaël Porcher, Isabelle Boutron, & Philippe Ravaud. (2019). The statistical significance of meta-analyses is frequently fragile: definition of a fragility index for meta-analyses. Journal of Clinical Epidemiology. 111. 32–40. 66 indexed citations
7.
8.
Atal, Ignacio, Ludovic Trinquart, Philippe Ravaud, & Raphaël Porcher. (2018). A mapping of 115,000 randomized trials revealed a mismatch between research effort and health needs in non–high-income regions. Journal of Clinical Epidemiology. 98. 123–132. 25 indexed citations
9.
Yordanov, Youri, Agnès Dechartres, Ignacio Atal, et al.. (2018). Avoidable waste of research related to outcome planning and reporting in clinical trials. BMC Medicine. 16(1). 87–87. 40 indexed citations
10.
Lerner, Ivan, Perrine Créquit, Philippe Ravaud, & Ignacio Atal. (2018). Automatic screening using word embeddings achieved high sensitivity and workload reduction for updating living network meta-analyses. Journal of Clinical Epidemiology. 108. 86–94. 18 indexed citations
11.
Iudici, Michele, Aïda Bafeta, Ignacio Atal, & Philippe Ravaud. (2018). Ten Years of Interventional Research in Systemic Sclerosis: A Systematic Mapping of Trial Registries. Arthritis Care & Research. 72(1). 140–148. 4 indexed citations
12.
Dechartres, Agnès, Ignacio Atal, Carolina Riveros, Joerg J Meerpohl, & Philippe Ravaud. (2018). Association Between Publication Characteristics and Treatment Effect Estimates. Annals of Internal Medicine. 169(6). 385–393. 24 indexed citations
13.
Zeitoun, Jean‐David, Joseph S. Ross, Ignacio Atal, et al.. (2018). Factors Associated With Postmarketing Research for Approved Indications for Novel Medicines Approved by Both the FDA and EMA Between 2005 and 2010: A Multivariable Analysis. Clinical Pharmacology & Therapeutics. 104(5). 1000–1007. 4 indexed citations
14.
Dechartres, Agnès, Ludovic Trinquart, Ignacio Atal, et al.. (2017). Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study. BMJ. 357. j2490–j2490. 111 indexed citations
15.
Zeitoun, Jean‐David, Joseph S. Ross, Ignacio Atal, et al.. (2017). Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study. BMJ Open. 7(12). e018587–e018587. 8 indexed citations
16.
Zeitoun, Jean‐David, Gabriel Baron, Alexandre Vivot, et al.. (2017). Post‐marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross‐sectional study. International Journal of Cancer. 142(2). 414–423. 11 indexed citations
17.
Dechartres, Agnès, Philippe Ravaud, Ignacio Atal, Carolina Riveros, & Isabelle Boutron. (2016). Association between trial registration and treatment effect estimates: a meta-epidemiological study. BMC Medicine. 14(1). 100–100. 51 indexed citations
18.
Atal, Ignacio, Jean‐David Zeitoun, Aurélie Névéol, et al.. (2016). Automatic classification of registered clinical trials towards the Global Burden of Diseases taxonomy of diseases and injuries. BMC Bioinformatics. 17(1). 392–392. 10 indexed citations
19.
Dechartres, Agnès, et al.. (2016). Reporting of statistically significant results at ClinicalTrials.gov for completed superiority randomized controlled trials. BMC Medicine. 14(1). 192–192. 3 indexed citations
20.
Atal, Ignacio, Ludovic Trinquart, Raphaël Porcher, & Philippe Ravaud. (2015). Differential Globalization of Industry- and Non-Industry–Sponsored Clinical Trials. PLoS ONE. 10(12). e0145122–e0145122. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cole Wayant Breakdown of academic impact, for papers by Nadera Ahmadzai Breakdown of academic impact, for papers by Elke Hausner Breakdown of academic impact, for papers by Kevin M. Fain Breakdown of academic impact, for papers by D. G. Altman Breakdown of academic impact, for papers by Graham Wheeler Breakdown of academic impact, for papers by Lang’o Odondi Breakdown of academic impact, for papers by Pamela Tenaerts Breakdown of academic impact, for papers by Natalie McGauran
Rankless by CCL
2026